Syntheses of Melanotan II and YSL Amide by Ajiphase® Methodology
- Authors: Sanguliya T.A.1, Antipova A.O.1, Shkavrov S.V.1, Épshtein N.B.1
- 
							Affiliations: 
							- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
 
- Issue: Vol 53, No 5 (2019)
- Pages: 462-466
- Section: Drug Synthesis Methods and Manufacturing Technology
- URL: https://ogarev-online.ru/0091-150X/article/view/245812
- DOI: https://doi.org/10.1007/s11094-019-02020-0
- ID: 245812
Cite item
Abstract
The promising antitumor peptides Melanotan II and YSL amide were synthesized for the first time in gram quantities in overall yields of 72 and 50%, respectively, by Ajiphase® methodology. This method was shown to be promising for peptide manufacturing. The proposed methods are as convenient as polymer-phase syntheses with the reagent consumption and associated analytical simplicity of classical solution syntheses.
About the authors
T. A. Sanguliya
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
														Email: NBEpshtejn@mephi.ru
				                					                																			                												                	Russian Federation, 							Moscow, 115409						
A. O. Antipova
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
														Email: NBEpshtejn@mephi.ru
				                					                																			                												                	Russian Federation, 							Moscow, 115409						
S. V. Shkavrov
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
														Email: NBEpshtejn@mephi.ru
				                					                																			                												                	Russian Federation, 							Moscow, 115409						
N. B. Épshtein
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
							Author for correspondence.
							Email: NBEpshtejn@mephi.ru
				                					                																			                												                	Russian Federation, 							Moscow, 115409						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					